European Healthtech startup funding raised during Q1 2016.
In Q1 2016, 72 European Healthtech companies raised a combined €510M across 74 funding rounds, up 106.8% versus Q1 2015. UK led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Oxford Nanopore Technologies | Growth/Late | Mar 2016 | €111M |
| MindMaze | Growth/Late | Jan 2016 | €92M |
| MedDay | Series B | Mar 2016 | €34M |
| G-Therapeutics | Series A |
9 exits · €1.3B disclosed.
| Arcam | Acquisition | Jan 2016 | €636M |
| Valtech Cardio | Acquisition | Mar 2016 | €628M |
| Mar 2016 |
| €26M |
| STAT-Diagnostica | Series C | Mar 2016 | €25M |
| Cambridge Epigenetix | Series B | Feb 2016 | €19M |
| Metabomed | Series A | Mar 2016 | €16M |
| MonDocteur | Growth/Late | Jan 2016 | €14M |
| Rythm | Series A | Feb 2016 | €10M |
| iSTAR Medical | Series B | Mar 2016 | €10M |
| Bluebee | Series A | Feb 2016 | €10M |
| G-Therapeutics | Debt | Mar 2016 | €10M |
| Medasense Biometrics | Series B | Feb 2016 | €7.3M |
| Silk Biomaterials | Series A | Mar 2016 | €7.0M |
| Kiweno | Early VC | Feb 2016 | €7.0M |
